EP1952817A4 - Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia - Google Patents
Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemiaInfo
- Publication number
- EP1952817A4 EP1952817A4 EP06823482A EP06823482A EP1952817A4 EP 1952817 A4 EP1952817 A4 EP 1952817A4 EP 06823482 A EP06823482 A EP 06823482A EP 06823482 A EP06823482 A EP 06823482A EP 1952817 A4 EP1952817 A4 EP 1952817A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- aloe vera
- vera extract
- hyperglycemia
- production
- ameliorating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000014104 aloe vera supplement Nutrition 0.000 title 2
- 201000001421 hyperglycemia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10157399.6A EP2206509B1 (en) | 2005-11-25 | 2006-11-20 | Method of producing aloe vera extract |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005340245 | 2005-11-25 | ||
PCT/JP2006/323095 WO2007060911A1 (en) | 2005-11-25 | 2006-11-20 | Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10157399.6A Division EP2206509B1 (en) | 2005-11-25 | 2006-11-20 | Method of producing aloe vera extract |
EP10157399.6 Division-Into | 2010-03-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1952817A1 EP1952817A1 (en) | 2008-08-06 |
EP1952817A4 true EP1952817A4 (en) | 2009-09-23 |
EP1952817B1 EP1952817B1 (en) | 2013-05-22 |
Family
ID=38067138
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06823482.2A Active EP1952817B1 (en) | 2005-11-25 | 2006-11-20 | Aloe vera extract, method of producing aloe vera extract, and hyperglycemia improving agent |
EP10157399.6A Active EP2206509B1 (en) | 2005-11-25 | 2006-11-20 | Method of producing aloe vera extract |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10157399.6A Active EP2206509B1 (en) | 2005-11-25 | 2006-11-20 | Method of producing aloe vera extract |
Country Status (10)
Country | Link |
---|---|
US (3) | US20090004307A1 (en) |
EP (2) | EP1952817B1 (en) |
JP (1) | JP4095115B2 (en) |
KR (1) | KR100897492B1 (en) |
CN (2) | CN103494998B (en) |
AU (1) | AU2006317258B2 (en) |
CA (1) | CA2602066C (en) |
ES (2) | ES2425149T3 (en) |
RU (1) | RU2356572C1 (en) |
WO (1) | WO2007060911A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005094838A1 (en) * | 2004-03-31 | 2005-10-13 | Morinaga Milk Industry Co., Ltd. | Drugs, foods and drinks for ameliorating hyperglycemia |
ES2719098T3 (en) * | 2008-11-19 | 2019-07-08 | Morinaga Milk Industry Co Ltd | Compositions comprising a lofenol |
JP4580041B2 (en) * | 2008-11-19 | 2010-11-10 | 森永乳業株式会社 | Antioxidant |
MX2012008982A (en) | 2010-02-03 | 2012-08-23 | Morinaga Milk Industry Co Ltd | Method for manufacturing aloe powder. |
DE102012222365A1 (en) | 2012-12-05 | 2014-06-05 | Aesculap Ag | Composition for use in the prophylaxis of post-surgical adhesions |
WO2015015815A1 (en) * | 2013-07-30 | 2015-02-05 | 森永乳業株式会社 | Fibroblast activator |
WO2015015816A1 (en) * | 2013-07-30 | 2015-02-05 | 森永乳業株式会社 | Fibroblast activator |
KR101520934B1 (en) * | 2013-12-30 | 2015-05-18 | 건국대학교 산학협력단 | Method of Preparing Aloe vera Extract Having Enhanced Antioxidant Activity |
WO2015141787A1 (en) * | 2014-03-20 | 2015-09-24 | 森永乳業株式会社 | Method for manufacturing aloe extract, and aloe extract |
CN106999503A (en) * | 2014-11-28 | 2017-08-01 | 森永乳业株式会社 | The prevention of the symptom caused by disorder balanced as sex hormone or improver |
JP6285050B2 (en) * | 2014-11-28 | 2018-02-28 | 森永乳業株式会社 | Matrix metalloprotease production inhibitor |
JP2019043863A (en) * | 2017-08-30 | 2019-03-22 | 森永乳業株式会社 | UCP expression promoter |
JP7239489B2 (en) | 2017-12-19 | 2023-03-14 | 森永乳業株式会社 | Method for producing aloe powder |
JP7245637B2 (en) * | 2018-11-30 | 2023-03-24 | 森永乳業株式会社 | Method for producing aloe extract |
EP4129434A4 (en) * | 2020-03-24 | 2024-04-24 | Morinaga Milk Industry Co., Ltd. | Supercritical fluid exraction device and method for manufacturing target product using same |
WO2022045354A1 (en) * | 2020-08-31 | 2022-03-03 | 森永乳業株式会社 | Method for producing phytosterol starting material |
WO2023054477A1 (en) * | 2021-09-28 | 2023-04-06 | 森永乳業株式会社 | Method for producing aloe extract |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011144A1 (en) * | 1997-09-02 | 1999-03-11 | The Ricex Company, Inc. | A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5942656B2 (en) | 1980-07-07 | 1984-10-16 | 森下製薬株式会社 | antilipidemic agent |
US4851224A (en) | 1986-06-05 | 1989-07-25 | Carrington Laboratories, Inc. | Process for preparation of aloe products |
US4801582A (en) | 1984-04-05 | 1989-01-31 | Toyo Yakushoku Kogyo Co., Ltd. | Method and composition for treating hypoglycemia using aloe polysaccharides |
JPS60214741A (en) | 1984-04-05 | 1985-10-28 | Toyo Yakushiyoku Kogyo Kk | Hypoglycemic agent |
JP3685833B2 (en) | 1995-02-06 | 2005-08-24 | 日本メナード化粧品株式会社 | Immunosuppression improving agent |
JP2844520B2 (en) | 1995-03-20 | 1999-01-06 | カーリントン ラボラトリーズ インコーポレーテッド | Aloe juice production method |
US5929051A (en) * | 1998-05-13 | 1999-07-27 | Carrington Laboratories, Inc. | Aloe pectins |
DE19916034C1 (en) | 1999-04-09 | 2000-08-03 | Cognis Deutschland Gmbh | Isolation of phytosterols following methyl esterification of rape seed or soya fatty acids comprises crystallization from 25 - 75 wt. % methanol, useful as hypocholesterolemic agents in drugs and foods |
JP4499209B2 (en) | 1999-05-10 | 2010-07-07 | 日本メナード化粧品株式会社 | Obesity prevention and improvement agent |
JP2002068997A (en) | 2000-08-23 | 2002-03-08 | Air Green Co Ltd | Aloe-vera stock solution and concentrate thereof |
JP2002205955A (en) | 2001-01-05 | 2002-07-23 | Daily Foods Kk | Colorless, transparent and additive-free 100% aloe vera pressed juice free from aloin |
JP4186176B2 (en) | 2001-03-27 | 2008-11-26 | デイリーフーズ株式会社 | Aloe vera press |
JP2002371003A (en) | 2001-06-15 | 2002-12-26 | Kikkoman Corp | Inhibitor against blood sugar level increase |
JP2003095941A (en) | 2001-09-26 | 2003-04-03 | Ito En Ltd | Sugar digestion enzyme inhibitor, hyperglycemia inhibitor, therapeutic or prophylactic agent for obesity, therapeutic or prophylactic agent for diabetes, and healthy food and drink |
JP2003113394A (en) | 2001-10-04 | 2003-04-18 | Unitika Ltd | Extract of konjak and food and drink including the same |
JP2003277269A (en) | 2002-03-20 | 2003-10-02 | Univ Nihon | Carcinogensis preventing agent |
JP2003286185A (en) | 2002-03-29 | 2003-10-07 | Daily Foods Kk | Squeezed liquid of aloe vera and hypoglycemic agent containing the squeezed liquid as effective ingredient |
JP4846990B2 (en) * | 2003-08-06 | 2011-12-28 | 株式会社テラ・ブレインズ | Adiponectin secretion promoter |
MY138963A (en) * | 2003-08-27 | 2009-08-28 | Malaysian Palm Oil Board | One-stage and two-stage supercritical fluid extractions of carotenes concentrate, vitamin e concentrate and other minor components concentrates |
WO2005094838A1 (en) * | 2004-03-31 | 2005-10-13 | Morinaga Milk Industry Co., Ltd. | Drugs, foods and drinks for ameliorating hyperglycemia |
MY146635A (en) * | 2004-09-01 | 2012-09-14 | Malaysian Palm Oil Board | Specialty palm oil products and other specialty vegetable oil products |
RU2327463C2 (en) * | 2004-09-29 | 2008-06-27 | Моринага Милк Индастри Ко., Лтд. | Medicinal agent and food substance or beverage for improved hyperglycemia |
-
2006
- 2006-11-20 KR KR1020077018270A patent/KR100897492B1/en active IP Right Grant
- 2006-11-20 CA CA2602066A patent/CA2602066C/en active Active
- 2006-11-20 EP EP06823482.2A patent/EP1952817B1/en active Active
- 2006-11-20 AU AU2006317258A patent/AU2006317258B2/en active Active
- 2006-11-20 CN CN201310334787.0A patent/CN103494998B/en active Active
- 2006-11-20 WO PCT/JP2006/323095 patent/WO2007060911A1/en active Application Filing
- 2006-11-20 EP EP10157399.6A patent/EP2206509B1/en active Active
- 2006-11-20 CN CN200680006127.8A patent/CN101128211B/en active Active
- 2006-11-20 ES ES06823482T patent/ES2425149T3/en active Active
- 2006-11-20 ES ES10157399.6T patent/ES2576845T3/en active Active
- 2006-11-20 US US11/815,428 patent/US20090004307A1/en not_active Abandoned
- 2006-11-20 RU RU2007137518/15A patent/RU2356572C1/en not_active IP Right Cessation
- 2006-11-20 JP JP2007546430A patent/JP4095115B2/en active Active
-
2010
- 2010-07-20 US US12/840,122 patent/US8877265B2/en active Active
-
2012
- 2012-11-19 US US13/680,658 patent/US8709512B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999011144A1 (en) * | 1997-09-02 | 1999-03-11 | The Ricex Company, Inc. | A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
Non-Patent Citations (4)
Title |
---|
CAN A ET AL: "Effect of Aloe vera Leaf Gel and Pulp Extracts on the Liver in Type-II Diabetic Rat Models", BIOLOGICAL & PHARMACEUTICAL BULLETIN (OF JAPAN), PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, vol. 27, no. 5, 1 May 2004 (2004-05-01), pages 694 - 698, XP002990130, ISSN: 0918-6158 * |
RAJASEKARAN S ET AL: "Hypoglycemic Effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats", JOURNAL OF MEDICINAL FOOD, MARY ANN LIEBERT, LARCHMONT, NY, US, vol. 7, no. 1, 1 January 2004 (2004-01-01), pages 61 - 66, XP003011589, ISSN: 1096-620X * |
See also references of WO2007060911A1 * |
YONGCHAIYUDHA S ET AL: "Antidiabetic activity of Aloe vera L.juice. I. Clinical trial in new cases of diabetes mellitus", PHYTOMEDICINE, GUSTAV FISCHER VERLAG, STUTTGART, vol. 3, no. 3, 1 January 1996 (1996-01-01), pages 241 - 243, XP003011590, ISSN: 0944-7113 * |
Also Published As
Publication number | Publication date |
---|---|
CN101128211A (en) | 2008-02-20 |
CN103494998B (en) | 2015-08-12 |
US8709512B2 (en) | 2014-04-29 |
JP4095115B2 (en) | 2008-06-04 |
EP2206509A1 (en) | 2010-07-14 |
AU2006317258A1 (en) | 2007-05-31 |
EP1952817B1 (en) | 2013-05-22 |
AU2006317258B2 (en) | 2008-12-18 |
US20090004307A1 (en) | 2009-01-01 |
CA2602066C (en) | 2014-02-11 |
CA2602066A1 (en) | 2007-05-31 |
US20110104314A1 (en) | 2011-05-05 |
KR20070096010A (en) | 2007-10-01 |
RU2356572C1 (en) | 2009-05-27 |
ES2576845T3 (en) | 2016-07-11 |
ES2425149T3 (en) | 2013-10-11 |
EP2206509B1 (en) | 2016-03-23 |
KR100897492B1 (en) | 2009-05-15 |
WO2007060911A1 (en) | 2007-05-31 |
JPWO2007060911A1 (en) | 2009-05-07 |
US20130079314A1 (en) | 2013-03-28 |
CN101128211B (en) | 2014-08-13 |
CN103494998A (en) | 2014-01-08 |
US8877265B2 (en) | 2014-11-04 |
EP1952817A1 (en) | 2008-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1952817A4 (en) | Aloe vera extract, process for production of aloe vera extract, and ameliorating agent for hyperglycemia | |
EP1934267A4 (en) | Aqueous-liquid-absorbing agent and its production process | |
IL184694A0 (en) | New polymorphous forms of rifazimin, processes for their production and use thereof in the medicinal | |
HK1140202A1 (en) | Novel pyridopyrazine derivatives, process of manufacturing and uses thereof | |
EP1729881A4 (en) | An aqueous-liquid-absorbing agent and its production process | |
HK1110306A1 (en) | Crude glycerol-based product, process for its purification and its use in the manufacture of dichloropropanol | |
EP2087903A4 (en) | Extract powder of indigo-containing plant, method for production thereof, and use thereof | |
EP1848758A4 (en) | Water absorbing agent, water absorbing article and method for production of water absorbing agent | |
EP1939231A4 (en) | (meth)acylate-grafted polyether polyol, and process for production and use thereof | |
IL193340A0 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
EP1895966A4 (en) | Method of extracting ginsengnoside rg2m, pharmaceutical composition including ginsengnoside rg2, and uses thereof | |
IL199472A0 (en) | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms, processes for the preparation of the same and uses thereof | |
EP2368544A4 (en) | Orally rapidly disintegrating tablet, and process for producing same | |
PL3403657T3 (en) | Use of oligouronates for treating mucus hyperviscosity | |
GB2445893B (en) | Chinese medicinal compositions useful as anti-fatigue, anti-aging and gonadotrophic agent and processes for preparation thereof | |
IL193341A0 (en) | Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
IL195270A (en) | Racecadotril tablets, process for their preparation and use of racecadotril in preparing tablets for treating diarrhea | |
EP2062599A4 (en) | Orally disintegrating tablet and process for production thereof | |
ZA200709081B (en) | High strength paper and process of manufacture | |
EP2019133A4 (en) | MICROORGANISM CAPABLE OF PRODUCING gamma-L-PGA, METHOD FOR PRODUCTION OF gamma-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN | |
PL2094652T3 (en) | Integrated process for urea and melamine production | |
EP2022829A4 (en) | Photoluminescent pigment, method for production of the pigment, and aqueous resin composition comprising the pigment | |
BRPI1013651A2 (en) | "process for producing soluble and clear cereal based extract" | |
EP1872669A4 (en) | Oxygen-containing reductive aqueous beverage and process for production of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20070813 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE ES FR GB IT |
|
DAX | Request for extension of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RBV | Designated contracting states (corrected) |
Designated state(s): DE ES FR GB IT |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20090824 |
|
17Q | First examination report despatched |
Effective date: 20091125 |
|
TPAC | Observations filed by third parties |
Free format text: ORIGINAL CODE: EPIDOSNTIPA |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): DE ES FR GB IT |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602006036490 Country of ref document: DE Effective date: 20130718 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2425149 Country of ref document: ES Kind code of ref document: T3 Effective date: 20131011 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20140225 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602006036490 Country of ref document: DE Effective date: 20140225 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20191202 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201121 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230509 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230928 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230929 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231010 Year of fee payment: 18 Ref country code: DE Payment date: 20230929 Year of fee payment: 18 |